Christina Ackermann is Director of Verona Pharma plc. Currently has a direct ownership of 41,880 shares of VRNA, which is worth approximately $1.57 Million. The most recent transaction as insider was on Nov 06, 2024, when has been sold 41,880 shares (Ordinary Shares) at a price of $4.74 per share, resulting in proceeds of $198,511. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41.9K
n/a 3M change
n/a 12M change
Total Value Held $1.57 Million

CHRISTINA ACKERMANN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 06 2024
BUY
Open market or private purchase
$198,511 $4.74 p/Share
41,880 Added 50.0%
41,880 Ordinary Shares

Also insider at

BHC
Bausch Health Companies Inc. Healthcare
GRAY
GRAYBUG VISION, INC. Healthcare
BLCO
Bausch & Lomb Corp Healthcare
CA

Christina Ackermann

Director
Vaughan, A6

Track Institutional and Insider Activities on VRNA

Follow Verona Pharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRNA shares.

Notify only if

Insider Trading

Get notified when an Verona Pharma PLC insider buys or sells VRNA shares.

Notify only if

News

Receive news related to Verona Pharma plc

Track Activities on VRNA